OPKO Health Announces License Agreement for OPKO’s Alzheimer’s Diagnostic Technology
Tuesday, April 3rd, 2012OPKO Health, Inc. today announced that it has signed an agreement with Laboratory Corporation of America Holdings under which LabCorp licensed exclusive rights in North America and the United Arab Emirates to OPKO’s intellectual property to develop and commercialize laboratory testing services for Alzheimer’s disease.
Original post:
... continue reading